📰 Daniel Speciale News
Daniel Speciale News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Daniel Speciale. Real-time updates on events, politics, business and more.
February 2, 2024
/PRNewswire/ -- Mallinckrodt plc ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced the appointments of Paul Bisaro,...
November 15, 2023
/PRNewswire/ -- Mallinckrodt plc ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced that it has completed its...
November 10, 2023
Mallinckrodt plc (in examination under Part 10 of the Companies Act 2014 of Ireland, and hereinafter "Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced that the High Court of Ireland (the "Irish High Court")...
November 10, 2023
Company Expects to Complete Irish Examinership and Emerge from Chapter 11 in Coming Days DUBLIN, Nov. 10, 2023 /PRNewswire/ -- Mallinckrodt plc (O...
November 10, 2023
/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKTQ) (in examination under Part 10 of the Companies Act 2014 of Ireland, and hereinafter "Mallinckrodt" or the...
October 10, 2023
/PRNewswire/ -- Mallinckrodt plc (in examinership) (OTCMKTS: MNKTQ) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today...
August 31, 2023
/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKTQ), a global specialty pharmaceutical company, today announced that its Specialty Generics segment, operating as...
August 30, 2023
/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKTQ) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced that it has...
August 28, 2023
/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced that it has...
August 23, 2023
Agreement Supported by a Substantial Majority of Each of its First and Second Lien Debtholders and Opioid Trust Financial Restructuring Plan to Significantly...